nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—Chlorphenesin—PTGS2—colon cancer	0.00404	0.275	CrCbGaD
Bisoprolol—Atenolol—ABCB1—colon cancer	0.00343	0.234	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—colon cancer	0.00317	0.216	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—colon cancer	0.00268	0.182	CrCbGaD
Bisoprolol—Erythema—Fluorouracil—colon cancer	0.00199	0.00202	CcSEcCtD
Bisoprolol—Bronchospasm—Capecitabine—colon cancer	0.00196	0.00199	CcSEcCtD
Bisoprolol—Agitation—Vincristine—colon cancer	0.00196	0.00199	CcSEcCtD
Bisoprolol—Photosensitivity—Methotrexate—colon cancer	0.00196	0.00199	CcSEcCtD
Bisoprolol—Polyuria—Methotrexate—colon cancer	0.00196	0.00199	CcSEcCtD
Bisoprolol—Sweating increased—Capecitabine—colon cancer	0.00194	0.00197	CcSEcCtD
Bisoprolol—Ill-defined disorder—Irinotecan—colon cancer	0.00193	0.00196	CcSEcCtD
Bisoprolol—Bronchitis—Capecitabine—colon cancer	0.00192	0.00195	CcSEcCtD
Bisoprolol—Vertigo—Vincristine—colon cancer	0.00192	0.00194	CcSEcCtD
Bisoprolol—Malaise—Irinotecan—colon cancer	0.00187	0.0019	CcSEcCtD
Bisoprolol—Vertigo—Irinotecan—colon cancer	0.00187	0.00189	CcSEcCtD
Bisoprolol—Syncope—Irinotecan—colon cancer	0.00186	0.00189	CcSEcCtD
Bisoprolol—Loss of consciousness—Irinotecan—colon cancer	0.00183	0.00185	CcSEcCtD
Bisoprolol—Dermatitis exfoliative—Methotrexate—colon cancer	0.00182	0.00185	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Capecitabine—colon cancer	0.00182	0.00185	CcSEcCtD
Bisoprolol—Myalgia—Vincristine—colon cancer	0.00182	0.00184	CcSEcCtD
Bisoprolol—Weight increased—Capecitabine—colon cancer	0.00182	0.00184	CcSEcCtD
Bisoprolol—Visual disturbance—Methotrexate—colon cancer	0.00181	0.00184	CcSEcCtD
Bisoprolol—Cough—Irinotecan—colon cancer	0.00181	0.00184	CcSEcCtD
Bisoprolol—Pneumonia—Capecitabine—colon cancer	0.00179	0.00182	CcSEcCtD
Bisoprolol—Depression—Capecitabine—colon cancer	0.00177	0.0018	CcSEcCtD
Bisoprolol—Acute coronary syndrome—Capecitabine—colon cancer	0.00175	0.00178	CcSEcCtD
Bisoprolol—Discomfort—Irinotecan—colon cancer	0.00175	0.00177	CcSEcCtD
Bisoprolol—Myocardial infarction—Capecitabine—colon cancer	0.00174	0.00177	CcSEcCtD
Bisoprolol—Oedema—Vincristine—colon cancer	0.00174	0.00177	CcSEcCtD
Bisoprolol—Infection—Vincristine—colon cancer	0.00173	0.00175	CcSEcCtD
Bisoprolol—Urinary tract infection—Capecitabine—colon cancer	0.00173	0.00175	CcSEcCtD
Bisoprolol—Conjunctivitis—Capecitabine—colon cancer	0.00173	0.00175	CcSEcCtD
Bisoprolol—Osteoarthritis—Methotrexate—colon cancer	0.00172	0.00174	CcSEcCtD
Bisoprolol—Confusional state—Irinotecan—colon cancer	0.00171	0.00173	CcSEcCtD
Bisoprolol—Nervous system disorder—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Bisoprolol—Thrombocytopenia—Vincristine—colon cancer	0.0017	0.00173	CcSEcCtD
Bisoprolol—Oedema—Irinotecan—colon cancer	0.0017	0.00172	CcSEcCtD
Bisoprolol—Chest pain—Fluorouracil—colon cancer	0.00169	0.00172	CcSEcCtD
Bisoprolol—Myalgia—Fluorouracil—colon cancer	0.00169	0.00172	CcSEcCtD
Bisoprolol—Infection—Irinotecan—colon cancer	0.00168	0.00171	CcSEcCtD
Bisoprolol—Hyperhidrosis—Vincristine—colon cancer	0.00168	0.00171	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Capecitabine—colon cancer	0.00168	0.00171	CcSEcCtD
Bisoprolol—Discomfort—Fluorouracil—colon cancer	0.00167	0.0017	CcSEcCtD
Bisoprolol—Shock—Irinotecan—colon cancer	0.00167	0.00169	CcSEcCtD
Bisoprolol—Nervous system disorder—Irinotecan—colon cancer	0.00166	0.00169	CcSEcCtD
Bisoprolol—Agranulocytosis—Capecitabine—colon cancer	0.00166	0.00168	CcSEcCtD
Bisoprolol—Thrombocytopenia—Irinotecan—colon cancer	0.00166	0.00168	CcSEcCtD
Bisoprolol—Hyperhidrosis—Irinotecan—colon cancer	0.00164	0.00166	CcSEcCtD
Bisoprolol—Confusional state—Fluorouracil—colon cancer	0.00164	0.00166	CcSEcCtD
Bisoprolol—Mood swings—Methotrexate—colon cancer	0.00163	0.00165	CcSEcCtD
Bisoprolol—Hypotension—Vincristine—colon cancer	0.00163	0.00165	CcSEcCtD
Bisoprolol—Bradycardia—Capecitabine—colon cancer	0.00163	0.00165	CcSEcCtD
Bisoprolol—Oedema—Fluorouracil—colon cancer	0.00162	0.00165	CcSEcCtD
Bisoprolol—Infection—Fluorouracil—colon cancer	0.00161	0.00164	CcSEcCtD
Bisoprolol—Rhinitis—Capecitabine—colon cancer	0.0016	0.00162	CcSEcCtD
Bisoprolol—Hepatitis—Capecitabine—colon cancer	0.0016	0.00162	CcSEcCtD
Bisoprolol—Nervous system disorder—Fluorouracil—colon cancer	0.00159	0.00162	CcSEcCtD
Bisoprolol—Thrombocytopenia—Fluorouracil—colon cancer	0.00159	0.00161	CcSEcCtD
Bisoprolol—Hypoaesthesia—Capecitabine—colon cancer	0.00159	0.00161	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00159	0.00161	CcSEcCtD
Bisoprolol—Pharyngitis—Capecitabine—colon cancer	0.00158	0.00161	CcSEcCtD
Bisoprolol—Tachycardia—Fluorouracil—colon cancer	0.00158	0.00161	CcSEcCtD
Bisoprolol—Hypotension—Irinotecan—colon cancer	0.00158	0.00161	CcSEcCtD
Bisoprolol—Insomnia—Vincristine—colon cancer	0.00157	0.0016	CcSEcCtD
Bisoprolol—Oedema peripheral—Capecitabine—colon cancer	0.00157	0.0016	CcSEcCtD
Bisoprolol—Connective tissue disorder—Capecitabine—colon cancer	0.00157	0.00159	CcSEcCtD
Bisoprolol—Paraesthesia—Vincristine—colon cancer	0.00156	0.00159	CcSEcCtD
Bisoprolol—Breast disorder—Methotrexate—colon cancer	0.00155	0.00158	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00155	0.00157	CcSEcCtD
Bisoprolol—Visual impairment—Capecitabine—colon cancer	0.00154	0.00156	CcSEcCtD
Bisoprolol—Insomnia—Irinotecan—colon cancer	0.00153	0.00156	CcSEcCtD
Bisoprolol—Paraesthesia—Irinotecan—colon cancer	0.00152	0.00154	CcSEcCtD
Bisoprolol—Hypotension—Fluorouracil—colon cancer	0.00152	0.00154	CcSEcCtD
Bisoprolol—Dyspnoea—Irinotecan—colon cancer	0.00151	0.00153	CcSEcCtD
Bisoprolol—Somnolence—Irinotecan—colon cancer	0.00151	0.00153	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Vincristine—colon cancer	0.0015	0.00153	CcSEcCtD
Bisoprolol—Fatigue—Vincristine—colon cancer	0.0015	0.00152	CcSEcCtD
Bisoprolol—Eye disorder—Capecitabine—colon cancer	0.00149	0.00151	CcSEcCtD
Bisoprolol—Dyspepsia—Irinotecan—colon cancer	0.00149	0.00151	CcSEcCtD
Bisoprolol—Tinnitus—Capecitabine—colon cancer	0.00149	0.00151	CcSEcCtD
Bisoprolol—Pain—Vincristine—colon cancer	0.00149	0.00151	CcSEcCtD
Bisoprolol—Constipation—Vincristine—colon cancer	0.00149	0.00151	CcSEcCtD
Bisoprolol—Asthma—Methotrexate—colon cancer	0.00149	0.00151	CcSEcCtD
Bisoprolol—Cardiac disorder—Capecitabine—colon cancer	0.00148	0.0015	CcSEcCtD
Bisoprolol—Flushing—Capecitabine—colon cancer	0.00148	0.0015	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00148	0.0015	CcSEcCtD
Bisoprolol—Insomnia—Fluorouracil—colon cancer	0.00147	0.00149	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Irinotecan—colon cancer	0.00146	0.00149	CcSEcCtD
Bisoprolol—Fatigue—Irinotecan—colon cancer	0.00146	0.00148	CcSEcCtD
Bisoprolol—Paraesthesia—Fluorouracil—colon cancer	0.00146	0.00148	CcSEcCtD
Bisoprolol—Constipation—Irinotecan—colon cancer	0.00145	0.00147	CcSEcCtD
Bisoprolol—Pain—Irinotecan—colon cancer	0.00145	0.00147	CcSEcCtD
Bisoprolol—Angiopathy—Capecitabine—colon cancer	0.00145	0.00147	CcSEcCtD
Bisoprolol—Dyspnoea—Fluorouracil—colon cancer	0.00145	0.00147	CcSEcCtD
Bisoprolol—Somnolence—Fluorouracil—colon cancer	0.00144	0.00146	CcSEcCtD
Bisoprolol—Mediastinal disorder—Capecitabine—colon cancer	0.00144	0.00146	CcSEcCtD
Bisoprolol—Dyspepsia—Fluorouracil—colon cancer	0.00143	0.00145	CcSEcCtD
Bisoprolol—Arrhythmia—Capecitabine—colon cancer	0.00143	0.00145	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Vincristine—colon cancer	0.00142	0.00144	CcSEcCtD
Bisoprolol—Alopecia—Capecitabine—colon cancer	0.00141	0.00143	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0014	0.00142	CcSEcCtD
Bisoprolol—Mental disorder—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Bisoprolol—Feeling abnormal—Irinotecan—colon cancer	0.0014	0.00142	CcSEcCtD
Bisoprolol—Erythema—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Bisoprolol—Pain—Fluorouracil—colon cancer	0.00139	0.00141	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Irinotecan—colon cancer	0.00139	0.00141	CcSEcCtD
Bisoprolol—Abdominal pain—Vincristine—colon cancer	0.00138	0.0014	CcSEcCtD
Bisoprolol—Body temperature increased—Vincristine—colon cancer	0.00138	0.0014	CcSEcCtD
Bisoprolol—Erectile dysfunction—Methotrexate—colon cancer	0.00137	0.00139	CcSEcCtD
Bisoprolol—Dysgeusia—Capecitabine—colon cancer	0.00136	0.00138	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Methotrexate—colon cancer	0.00136	0.00138	CcSEcCtD
Bisoprolol—Propranolol—ABCB1—colon cancer	0.00135	0.0921	CrCbGaD
Bisoprolol—Back pain—Capecitabine—colon cancer	0.00134	0.00136	CcSEcCtD
Bisoprolol—Body temperature increased—Irinotecan—colon cancer	0.00134	0.00136	CcSEcCtD
Bisoprolol—Abdominal pain—Irinotecan—colon cancer	0.00134	0.00136	CcSEcCtD
Bisoprolol—Feeling abnormal—Fluorouracil—colon cancer	0.00134	0.00136	CcSEcCtD
Bisoprolol—Muscle spasms—Capecitabine—colon cancer	0.00134	0.00136	CcSEcCtD
Bisoprolol—Pneumonia—Methotrexate—colon cancer	0.00133	0.00135	CcSEcCtD
Bisoprolol—Drowsiness—Methotrexate—colon cancer	0.00132	0.00134	CcSEcCtD
Bisoprolol—Depression—Methotrexate—colon cancer	0.00132	0.00134	CcSEcCtD
Bisoprolol—Tremor—Capecitabine—colon cancer	0.0013	0.00132	CcSEcCtD
Bisoprolol—Ill-defined disorder—Capecitabine—colon cancer	0.00129	0.00131	CcSEcCtD
Bisoprolol—Urticaria—Fluorouracil—colon cancer	0.00129	0.00131	CcSEcCtD
Bisoprolol—Conjunctivitis—Methotrexate—colon cancer	0.00129	0.00131	CcSEcCtD
Bisoprolol—Body temperature increased—Fluorouracil—colon cancer	0.00128	0.0013	CcSEcCtD
Bisoprolol—Hypersensitivity—Vincristine—colon cancer	0.00128	0.0013	CcSEcCtD
Bisoprolol—Sweating—Methotrexate—colon cancer	0.00127	0.00129	CcSEcCtD
Bisoprolol—Malaise—Capecitabine—colon cancer	0.00125	0.00127	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Methotrexate—colon cancer	0.00125	0.00127	CcSEcCtD
Bisoprolol—Vertigo—Capecitabine—colon cancer	0.00125	0.00127	CcSEcCtD
Bisoprolol—Hypersensitivity—Irinotecan—colon cancer	0.00125	0.00127	CcSEcCtD
Bisoprolol—Asthenia—Vincristine—colon cancer	0.00125	0.00127	CcSEcCtD
Bisoprolol—Syncope—Capecitabine—colon cancer	0.00125	0.00127	CcSEcCtD
Bisoprolol—Agranulocytosis—Methotrexate—colon cancer	0.00124	0.00125	CcSEcCtD
Bisoprolol—Palpitations—Capecitabine—colon cancer	0.00123	0.00125	CcSEcCtD
Bisoprolol—Loss of consciousness—Capecitabine—colon cancer	0.00122	0.00124	CcSEcCtD
Bisoprolol—Asthenia—Irinotecan—colon cancer	0.00122	0.00123	CcSEcCtD
Bisoprolol—Cough—Capecitabine—colon cancer	0.00121	0.00123	CcSEcCtD
Bisoprolol—Hypersensitivity—Fluorouracil—colon cancer	0.0012	0.00121	CcSEcCtD
Bisoprolol—Diarrhoea—Vincristine—colon cancer	0.00119	0.00121	CcSEcCtD
Bisoprolol—Hepatitis—Methotrexate—colon cancer	0.00119	0.00121	CcSEcCtD
Bisoprolol—Chest pain—Capecitabine—colon cancer	0.00118	0.0012	CcSEcCtD
Bisoprolol—Arthralgia—Capecitabine—colon cancer	0.00118	0.0012	CcSEcCtD
Bisoprolol—Myalgia—Capecitabine—colon cancer	0.00118	0.0012	CcSEcCtD
Bisoprolol—Pharyngitis—Methotrexate—colon cancer	0.00118	0.0012	CcSEcCtD
Bisoprolol—Anxiety—Capecitabine—colon cancer	0.00118	0.0012	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00118	0.00119	CcSEcCtD
Bisoprolol—Discomfort—Capecitabine—colon cancer	0.00117	0.00119	CcSEcCtD
Bisoprolol—Diarrhoea—Irinotecan—colon cancer	0.00116	0.00118	CcSEcCtD
Bisoprolol—Dry mouth—Capecitabine—colon cancer	0.00116	0.00117	CcSEcCtD
Bisoprolol—Dizziness—Vincristine—colon cancer	0.00115	0.00117	CcSEcCtD
Bisoprolol—Pruritus—Fluorouracil—colon cancer	0.00115	0.00117	CcSEcCtD
Bisoprolol—Visual impairment—Methotrexate—colon cancer	0.00115	0.00116	CcSEcCtD
Bisoprolol—Confusional state—Capecitabine—colon cancer	0.00114	0.00116	CcSEcCtD
Bisoprolol—Oedema—Capecitabine—colon cancer	0.00113	0.00115	CcSEcCtD
Bisoprolol—Infection—Capecitabine—colon cancer	0.00113	0.00114	CcSEcCtD
Bisoprolol—Dizziness—Irinotecan—colon cancer	0.00112	0.00114	CcSEcCtD
Bisoprolol—Shock—Capecitabine—colon cancer	0.00112	0.00113	CcSEcCtD
Bisoprolol—Nervous system disorder—Capecitabine—colon cancer	0.00111	0.00113	CcSEcCtD
Bisoprolol—Eye disorder—Methotrexate—colon cancer	0.00111	0.00113	CcSEcCtD
Bisoprolol—Diarrhoea—Fluorouracil—colon cancer	0.00111	0.00113	CcSEcCtD
Bisoprolol—Thrombocytopenia—Capecitabine—colon cancer	0.00111	0.00113	CcSEcCtD
Bisoprolol—Tinnitus—Methotrexate—colon cancer	0.00111	0.00112	CcSEcCtD
Bisoprolol—Tachycardia—Capecitabine—colon cancer	0.00111	0.00112	CcSEcCtD
Bisoprolol—Vomiting—Vincristine—colon cancer	0.00111	0.00112	CcSEcCtD
Bisoprolol—Cardiac disorder—Methotrexate—colon cancer	0.0011	0.00112	CcSEcCtD
Bisoprolol—Skin disorder—Capecitabine—colon cancer	0.0011	0.00112	CcSEcCtD
Bisoprolol—Rash—Vincristine—colon cancer	0.0011	0.00111	CcSEcCtD
Bisoprolol—Hyperhidrosis—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Bisoprolol—Dermatitis—Vincristine—colon cancer	0.0011	0.00111	CcSEcCtD
Bisoprolol—Headache—Vincristine—colon cancer	0.00109	0.00111	CcSEcCtD
Bisoprolol—Angiopathy—Methotrexate—colon cancer	0.00108	0.00109	CcSEcCtD
Bisoprolol—Vomiting—Irinotecan—colon cancer	0.00108	0.00109	CcSEcCtD
Bisoprolol—Dizziness—Fluorouracil—colon cancer	0.00107	0.00109	CcSEcCtD
Bisoprolol—Mediastinal disorder—Methotrexate—colon cancer	0.00107	0.00109	CcSEcCtD
Bisoprolol—Rash—Irinotecan—colon cancer	0.00107	0.00108	CcSEcCtD
Bisoprolol—Dermatitis—Irinotecan—colon cancer	0.00107	0.00108	CcSEcCtD
Bisoprolol—Headache—Irinotecan—colon cancer	0.00106	0.00108	CcSEcCtD
Bisoprolol—Hypotension—Capecitabine—colon cancer	0.00106	0.00108	CcSEcCtD
Bisoprolol—Alopecia—Methotrexate—colon cancer	0.00105	0.00107	CcSEcCtD
Bisoprolol—Mental disorder—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Bisoprolol—Erythema—Methotrexate—colon cancer	0.00103	0.00105	CcSEcCtD
Bisoprolol—Nausea—Vincristine—colon cancer	0.00103	0.00105	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00103	0.00105	CcSEcCtD
Bisoprolol—Vomiting—Fluorouracil—colon cancer	0.00103	0.00105	CcSEcCtD
Bisoprolol—Insomnia—Capecitabine—colon cancer	0.00103	0.00104	CcSEcCtD
Bisoprolol—Rash—Fluorouracil—colon cancer	0.00102	0.00104	CcSEcCtD
Bisoprolol—Dermatitis—Fluorouracil—colon cancer	0.00102	0.00104	CcSEcCtD
Bisoprolol—Paraesthesia—Capecitabine—colon cancer	0.00102	0.00103	CcSEcCtD
Bisoprolol—Headache—Fluorouracil—colon cancer	0.00102	0.00103	CcSEcCtD
Bisoprolol—Dysgeusia—Methotrexate—colon cancer	0.00101	0.00103	CcSEcCtD
Bisoprolol—Dyspnoea—Capecitabine—colon cancer	0.00101	0.00103	CcSEcCtD
Bisoprolol—Nausea—Irinotecan—colon cancer	0.00101	0.00102	CcSEcCtD
Bisoprolol—Back pain—Methotrexate—colon cancer	0.001	0.00102	CcSEcCtD
Bisoprolol—Dyspepsia—Capecitabine—colon cancer	0.000999	0.00101	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Capecitabine—colon cancer	0.000979	0.000994	CcSEcCtD
Bisoprolol—Fatigue—Capecitabine—colon cancer	0.000978	0.000993	CcSEcCtD
Bisoprolol—Constipation—Capecitabine—colon cancer	0.00097	0.000985	CcSEcCtD
Bisoprolol—Pain—Capecitabine—colon cancer	0.00097	0.000985	CcSEcCtD
Bisoprolol—Nausea—Fluorouracil—colon cancer	0.000964	0.000979	CcSEcCtD
Bisoprolol—Ill-defined disorder—Methotrexate—colon cancer	0.00096	0.000974	CcSEcCtD
Bisoprolol—Feeling abnormal—Capecitabine—colon cancer	0.000935	0.000949	CcSEcCtD
Bisoprolol—Malaise—Methotrexate—colon cancer	0.000933	0.000947	CcSEcCtD
Bisoprolol—Vertigo—Methotrexate—colon cancer	0.00093	0.000944	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Capecitabine—colon cancer	0.000928	0.000941	CcSEcCtD
Bisoprolol—Cough—Methotrexate—colon cancer	0.000903	0.000916	CcSEcCtD
Bisoprolol—Urticaria—Capecitabine—colon cancer	0.000901	0.000915	CcSEcCtD
Bisoprolol—Abdominal pain—Capecitabine—colon cancer	0.000897	0.00091	CcSEcCtD
Bisoprolol—Body temperature increased—Capecitabine—colon cancer	0.000897	0.00091	CcSEcCtD
Bisoprolol—Arthralgia—Methotrexate—colon cancer	0.000881	0.000894	CcSEcCtD
Bisoprolol—Chest pain—Methotrexate—colon cancer	0.000881	0.000894	CcSEcCtD
Bisoprolol—Myalgia—Methotrexate—colon cancer	0.000881	0.000894	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000875	0.000888	CcSEcCtD
Bisoprolol—Discomfort—Methotrexate—colon cancer	0.00087	0.000883	CcSEcCtD
Bisoprolol—Confusional state—Methotrexate—colon cancer	0.000852	0.000864	CcSEcCtD
Bisoprolol—Infection—Methotrexate—colon cancer	0.000839	0.000851	CcSEcCtD
Bisoprolol—Hypersensitivity—Capecitabine—colon cancer	0.000836	0.000848	CcSEcCtD
Bisoprolol—Nervous system disorder—Methotrexate—colon cancer	0.000828	0.000841	CcSEcCtD
Bisoprolol—Thrombocytopenia—Methotrexate—colon cancer	0.000827	0.000839	CcSEcCtD
Bisoprolol—Skin disorder—Methotrexate—colon cancer	0.00082	0.000833	CcSEcCtD
Bisoprolol—Hyperhidrosis—Methotrexate—colon cancer	0.000816	0.000829	CcSEcCtD
Bisoprolol—Asthenia—Capecitabine—colon cancer	0.000814	0.000826	CcSEcCtD
Bisoprolol—Pruritus—Capecitabine—colon cancer	0.000803	0.000815	CcSEcCtD
Bisoprolol—Hypotension—Methotrexate—colon cancer	0.000789	0.000801	CcSEcCtD
Bisoprolol—Diarrhoea—Capecitabine—colon cancer	0.000776	0.000788	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000769	0.000781	CcSEcCtD
Bisoprolol—Insomnia—Methotrexate—colon cancer	0.000764	0.000775	CcSEcCtD
Bisoprolol—Paraesthesia—Methotrexate—colon cancer	0.000758	0.00077	CcSEcCtD
Bisoprolol—Dyspnoea—Methotrexate—colon cancer	0.000753	0.000764	CcSEcCtD
Bisoprolol—Somnolence—Methotrexate—colon cancer	0.000751	0.000762	CcSEcCtD
Bisoprolol—Dizziness—Capecitabine—colon cancer	0.00075	0.000761	CcSEcCtD
Bisoprolol—Dyspepsia—Methotrexate—colon cancer	0.000743	0.000754	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Methotrexate—colon cancer	0.000729	0.00074	CcSEcCtD
Bisoprolol—Fatigue—Methotrexate—colon cancer	0.000728	0.000739	CcSEcCtD
Bisoprolol—Pain—Methotrexate—colon cancer	0.000722	0.000733	CcSEcCtD
Bisoprolol—Vomiting—Capecitabine—colon cancer	0.000721	0.000732	CcSEcCtD
Bisoprolol—Rash—Capecitabine—colon cancer	0.000715	0.000726	CcSEcCtD
Bisoprolol—Dermatitis—Capecitabine—colon cancer	0.000715	0.000725	CcSEcCtD
Bisoprolol—Headache—Capecitabine—colon cancer	0.000711	0.000721	CcSEcCtD
Bisoprolol—Feeling abnormal—Methotrexate—colon cancer	0.000696	0.000706	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Methotrexate—colon cancer	0.000691	0.000701	CcSEcCtD
Bisoprolol—Nausea—Capecitabine—colon cancer	0.000674	0.000684	CcSEcCtD
Bisoprolol—Urticaria—Methotrexate—colon cancer	0.000671	0.000681	CcSEcCtD
Bisoprolol—Body temperature increased—Methotrexate—colon cancer	0.000668	0.000678	CcSEcCtD
Bisoprolol—Abdominal pain—Methotrexate—colon cancer	0.000668	0.000678	CcSEcCtD
Bisoprolol—Hypersensitivity—Methotrexate—colon cancer	0.000622	0.000631	CcSEcCtD
Bisoprolol—Asthenia—Methotrexate—colon cancer	0.000606	0.000615	CcSEcCtD
Bisoprolol—Pruritus—Methotrexate—colon cancer	0.000598	0.000606	CcSEcCtD
Bisoprolol—Diarrhoea—Methotrexate—colon cancer	0.000578	0.000586	CcSEcCtD
Bisoprolol—Dizziness—Methotrexate—colon cancer	0.000558	0.000567	CcSEcCtD
Bisoprolol—Vomiting—Methotrexate—colon cancer	0.000537	0.000545	CcSEcCtD
Bisoprolol—Rash—Methotrexate—colon cancer	0.000532	0.00054	CcSEcCtD
Bisoprolol—Dermatitis—Methotrexate—colon cancer	0.000532	0.00054	CcSEcCtD
Bisoprolol—Headache—Methotrexate—colon cancer	0.000529	0.000537	CcSEcCtD
Bisoprolol—Nausea—Methotrexate—colon cancer	0.000502	0.000509	CcSEcCtD
